Square Pharmaceuticals Limited

Square Pharmaceuticals is the flagship company of Square group which is one of the largest conglomerate in the country. The group’s turnover was over 1 billion US Dollar (2016) and employs over 47,000 people. Square pharmaceuticals is in manufacturing and marketing of finished pharmaceuticals products for the last 60 years. Manufacture of Active Pharmaceutical Ingredients (API) is a part of company business since in 1995. Since 1985 Square Pharma is the leader of Bangladesh Pharma market. 2015-2016 gross turnover of the company was over USD 544 Million (approx). The company has 13 manufacturing units in 2 different sites (Dhaka Site and Pabna Site) in Bangladesh. Two other manufacturing units are under construction at Dhaka site and commissioning of those units are expected to be completed by end of 2019. Solid dosage manufacturing unit has been approved by UK MHRA, MCC South Africa and TGA, Australia. The company is working on submission of several ANDAs and the first has been submited to US FDA in 2012. Square’s R&D center is well equipped with State-of-the-Art analytical tools. All the products are developed in-house for filing to regulated markets.